Tech Company Financing Transactions
Geneos Therapeutics Funding Round
3B Future Health Fund participated in a $5 million Series A funding round for Geneos Therapeutics. The financing round was announced on 4/12/2023.
Transaction Overview
Company Name
Announced On
4/12/2023
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
3B Future Health Fund (Lead Investor)
Proceeds Purpose
The company intends to use the capital for expansion of phase 1b/2a trial of personalized therapeutic cancer vaccine in liver cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
660 West Germantown Pike LL 100
Plymouth Meeting, PA 19462
USA
Plymouth Meeting, PA 19462
USA
Phone
Undisclosed
Website
Email Address
Overview
At Geneos Therapeutics, we believe that personalized therapies are the future of cancer treatment. Our passion is to develop personalized therapies to unleash the most powerful force against cancer -- your body's own immune system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Niranjan Sardesai
Chief Financial Officer
Federica O'Brien
VP - Bus. Development
Hakim Hammach
VP - Operations
Joann Peters
VP - R & D
Alfredo Perales-Puchalt
Browse more venture capital transactions:
Prev: 4/12/2023: Function Oncology venture capital transaction
Next: 4/12/2023: Cybersyn venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs